Scientists find natural mimetics of anti-cancer, anti-aging drugs metformin and rapamycin

November 29, 2017, Biogerontology Research Foundation
AI-driven drug discovery. Credit: Insilico Medicine

Researchers from the Biogerontology Research Foundation, Insilico Medicine, Life Extension and other institutions have published a study in the journal Aging on the identification of natural mimetics of metformin and rapamycin. Metformin, a common type 2 diabetes drug, and rapamycin, a common anti-rejection drug, have both been shown to have substantial anti-aging and anti-cancer effects in a variety of model organisms. However, both compounds have known side effects and are regulated drugs for specific disease indications, factors that problematize their off-label use as healthspan-extending drugs.

In this study, the researchers applied deep-learning neural networks to profile the safety and gene- and pathway-level similarity of more than 800 to metformin and in an effort to identify natural compounds that can mimic the effects of these anti-cancer and anti-aging drugs while remaining free of the adverse effects associated with them.

"Earlier this year, we launched Young.AI, a comprehensive system utilizing the recent advances in deep learning for tracking a variety of aging biomarkers. One of the goals of our group is to identify the combinations of molecules that achieve the desired effects," said Alex Zhavoronkov, Ph.D., co-author of the study.

Their analysis identified many previously unreported metformin and rapamycin mimetics. In particular, they identified allantoin and ginsenoside as strong mimetics of metformin, epigallocatechin gallate and isoliquiritigenin as strong mimetics of rapamycin, and withaferin A as a strong mimetic of both. Additionally, their analysis also identified four previously unexplored natural compounds as fairly strong mimetics of rapamycin.

"Aging is not recognized as a disease, so we need strong potential geroprotectors of natural origin on the market—supplements that slow down aging, affecting the key mechanisms of aging at the molecular and cellular level," said Alexey Moskalev, Ph.D., a co-author of the study.

These findings are significant because, as naturally occurring compounds, such nutraceuticals are not subject to regulation by the FDA and other regulatory bodies. Furthermore, because the researchers induced a deep-learning-based classification of the safety profiles associated with these compounds, the novel candidate mimetics the study identified are likely to have less than metformin and rapamycin, though this needs to be further validated by clinical testing.

"This study is significant not only for the identification of novel candidate mimetics of and rapamycin, which as natural compounds are not subject to regulatory bodies like the FDA and which have higher-scoring safety profiles as indicated by our deep-learned safety profile classification analysis, but also for demonstrating particularly powerful screening methods that can be applied to the identification of novel and safe mimetics of other known anti-cancer and healthspan-extending drugs and ," said Franco Cortese, co-author of the study and Deputy Director of the Biogerontology Research Foundation.

Explore further: Face cream ingredient found to mimic life-extending effects of a calorie restriction diet

More information: Alexander Aliper et al, Towards natural mimetics of metformin and rapamycin, Aging (2017). DOI: 10.18632/aging.101319

Related Stories

Face cream ingredient found to mimic life-extending effects of a calorie restriction diet

December 16, 2015
A commonly used skin care ingredient is one of several newly identified compounds that can mimic the life-extending effect of a starvation diet, new University of Liverpool research has revealed.

Study shows promising safety results for anti-aging drug

February 9, 2016
The search for the fountain of youth led to a 2009 discovery that a drug called rapamycin was shown to extend the lifespan of mice. Since that time, studies on the metabolic side effects of rapamycin have made it unclear ...

Benchmark database of lifespan-extending drugs announced

March 14, 2017
Scientists from the Biogerontology Research Foundation (BGRF) and University of Liverpool have announced a landmark database of lifespan-extending drugs and compounds called DrugAge. The database has 418 compounds, curated ...

Combination approach improves power of new cancer therapy

June 26, 2017
An international research team has found a way to improve the anti-cancer effect of a new medicine class called 'Smac mimetics'.

New function discovered for compound that may help slow aging

April 5, 2017
Researchers at Oregon State University have found that a compound called rapamycin has unusual properties that may help address neurologic damage such as Alzheimer's disease.

Researchers discover new way to screen for cancer-killing drugs

February 3, 2016
A technique called "mito-priming" is the latest method to be developed by researchers in the fight against cancer.

Recommended for you

Scientists grow functioning human neural networks in 3-D from stem cells

October 18, 2018
A team of Tufts University-led researchers has developed three-dimensional (3-D) human tissue culture models for the central nervous system that mimic structural and functional features of the brain and demonstrate neural ...

Functional engineered oesophagus could pave way for clinical trials 

October 18, 2018
The world's first functional oesophagus engineered from stem cells has been grown and successfully transplanted into mice, as part of a pioneering new study led by UCL.

New findings cast light on lymphatic system, key player in human health

October 16, 2018
Scientists at the Oklahoma Medical Research Foundation have broken new ground in understanding how the lymphatic system works, potentially opening the door for future therapies.

New model suggests cuffless, non-invasive blood pressure monitoring possible using pulse waves

October 16, 2018
A large team of researchers from several institutions in China and the U.S. has developed a model that suggests it should be possible to create a cuffless, non-invasive blood pressure monitor based on measuring pulse waves. ...

Age-related increase in estrogen may cause common men's hernia

October 16, 2018
An age-related increase in estrogen may be the culprit behind inguinal hernias, a condition common among elderly men that often requires corrective surgery, according to a Northwestern Medicine study was published Oct. 15 ...

Income and wealth affect the mental health of Australians, study shows

October 16, 2018
Australians who have higher incomes and greater wealth are more likely to experience better mental health throughout their lives, new research led by the Bankwest Curtin Economics Centre has found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.